Angiogenesis is a normal and vital process in growth and development, as well as in wound healing and in the formation of granulation tissue. However, it is also a fundamental step in the transition of tumors from a benign state to a malignant one, leading to the use of angiogenesis inhibitors in the treatment of cancer.
Angiogenesis
- Foretinib (GSK1363089), Vascular endothelial growth factor receptor inhibitor
Cas#:849217-64-7
Starting at $64.90
-
- Fostamatinib Disodium Hexahydrate, Tyrosine-protein kinase SYK inhibitor
Cas#:914295-16-2
Starting at $22.90
-
-
-
-
-
-
- Neratinib (HKI-272), Receptor protein-tyrosine kinase erbB-4 inhibitor
Cas#:698387-09-6
Starting at $19.90
-
- Nintedanib (BIBF 1120), Inhibitor of fibroblast growth factor receptor 1;Inhibitor of fibroblast growth factor receptor 2;Inhibitor of fibroblast growth factor receptor 3;Inhibitor of fibroblast growth factor receptor 4;Inhibitor of fms related receptor tyrosine kinase 1;Inhibit
Cas#:656247-17-5
Starting at $28.90
-
-
- SU 6656, Inhibitor of aurora kinase B;Inhibitor of aurora kinase C;Inhibitor of BR serine/threonine kinase 2;Inhibitor of LCK proto-oncogene; Src family tyrosine kinase;Inhibitor of LYN proto-oncogene; Src family tyrosine kinase;Inhibitor of SRC proto-oncogene; no
Cas#:330161-87-0
Starting at $94.90
